HER2‑positive breast cancer immunotherapy: a focus on vaccine development

• Autorzy: Arab A. , Yazdian-Robati R. , Behravan J.
• Języki publikacji: EN

Abstrakty

EN

Słowa kluczowe

EN

breast cancer; immunotherapy; regulatory mechanism; tumour microenvironment; monoclonal antibody; vaccine; epidermal growth factor receptor 2; patient

• Wydawca: -
• Czasopismo: Archivum Immunologiae et Therapiae Experimentalis
• Rocznik: 2020
• Tom: 68
• Numer: 1
• Opis fizyczny: Article 2 [18p.], ref.

Twórcy

autor

Arab A.

• Pharmaceutical Sciences Research Center, Ardabil University of Medical Sciences, Ardabil, Iran

autor

Yazdian-Robati R.

• Molecular and Cell Biology Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran

autor

Behravan J.

• Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
• School of Pharmacy, University of Waterloo, Waterloo, ON, Canada
• Theraphage Inc., Kitchener, ON, Canada

Identyfikatory

DOI

10.1007/s00005-019-00566-1